More than $4 Billion is spent per year on mammography in the United States alone. Despite the expense, the results are not encouraging; more than 80% of the time something is found it turns out to be a false positive. It is also estimated that 10% of all cancers are missed. Mammography is even less effective in dense breasts. A suite of alternative technologies, including 3D mammography, are being employed here.
NovaScan has replaced the guts of a mammography machine with our technology that measures the Cole relaxation frequency. We then conducted a study across fifty patients that screened for breast cancer, across a diverse group of patients with dense and non-dense breasts. The results were perfect:
In an IRB Approved study of fifty patients, the NovaScan system was perfect in locating cancer, with no false positives and no false negatives, in dense and non-dense breasts